Lantibiotics are lanthionine containing peptide natural products that belong to the class of 8 ribosomally synthesized and post-translationally modified peptides (RiPPs). Recent expansion 9 in the availability of microbial genomic data and in silico analysis tools have accelerated the 10 discovery of these promising alternatives to antibiotics. Following the genome-mining 11 approach, a biosynthetic gene cluster for a putative two-component lantibiotic roseocin was 12 identified in the genome of an actinomycete, Streptomyces roseosporus NRRL 11379. Post-13 translationally modified lanthipeptides of this cluster were obtained by heterologous expression 14 of the genes in E. coli, and in vitro reconstituted to their bioactive form. The two lanthipeptides 15 displayed antimicrobial activity against Gram-positive bacteria only in synergy, reminiscent of 16 a two-component lantibiotic. Structural analysis of the α-component identified a disulfide 17 bridge flanking two of its four thioether bridges and the β-component having six thioether 18 bridges with its C-terminus extended than the previously known two-component lantibiotics. 19 20 roseocin, synergistic, thioether 21 24 of antimicrobial compounds that this genus produces includes polyketides, non-ribosomal, and 25 ribosomal peptides. Recent studies have focussed on the discovery of ribosomally synthesized 26 and post-translationally modified peptides (RiPPs) in light of the need for novel antimicrobials 27
INTRODUCTION 22
Many of the clinically used antibiotics are derived from the genus Streptomyces. It is the largest 23 genus of the Actinobacteria, Gram-positive and has a high GC content genome. The arsenal comparatively extended on the C-terminus was designated as RosA1β. In general, αand β-100 core peptides of roseocin are extended than those are previously characterized. ; Fig. 3 ). For His6-mRosA1, alkylation did not lead 173 to any change in its mass indicating that none of the six cysteine residues are free and that all 174 are cyclized ( Fig. 1B) . Since both the RosA peptides contain six cysteine residues with nine 175 and four dehydrated Ser/Thr residues, it indicated the presence of six and four thioether rings 194 195 RosA peptides contain overlapping thioether rings with a disulfide bond in RosA2α' 196 Both the lanthipeptides were subjected to MALDI-TOF MS/MS for structural analysis. By 197 using multiple sequence alignment (MSA) of RosA peptides, the conserved GA/GG motif was 198 identified which demarcates the boundary between the leader and the core peptide ( Fig. 1B) . and 5 th Glu residues for RosA1 and RosA2, respectively ( Fig. 2C and 2D ). These leader peptide 210 removed RosA peptides with the trace of leader peptide were termed as RosA2α' and RosA1β'. y 41 y 40 y 39 y 38 y 37 y 36 y 35 y 34 y 33 y 32 y 31 y 30 y 28 y 27 y 26 y 25 y 24 y 23 y 22 y 18 y 17 y 9 y 8 RosA2α', indicating an addition of two protons to the disulfide bonded Cys residues (Fig. S2) . 222 Reduction of RosA2α' also led to an enhancement in fragmentation ( Fig. 4A and S3) and Cys13 and Cys33 residues to be carbamidomethylated (Fig. S4) . Identification of distant 229 cysteines as disulfide partners indicated RosA2α' to be having a conformationally constrained 230 structure. Also, no fragment ions were observed in two long stretches indicating the presence 231 of thioether bridges (Fig. 4A ). For RosA1β', MS/MS data along with the absence of alkylation,
232
suggested cyclization of all the six cysteines into lanthionine rings (Fig. 4B ). Fragment ions 233 were majorly observed for the N-terminus and a few ions in the C-terminus indicating 234 lanthionine protection (Table S3 ). RosA2α' and RosA1β' did not display any antimicrobial activity when tested individually, but 256 a zone of inhibition was observed against Gram-positive bacteria when both the peptides were 257 spotted together (Table 1) . Uncleaved His6-mRosA1 and His6-mRosA2 peptides alone and in 258 combination did not display any antimicrobial activity, as was expected from a leader peptide 259 attached lantibiotic (Fig. 5) . Such a synergistic antimicrobial activity of two separate post- conditions in which the culture can be induced for the secondary metabolite production.
281
However, the currently followed in silico approach promises the identification of potential 282 producers which can then be confidently taken up for wet lab experiments. In our initial attempt 283 to identify class II lantibiotic biosynthetic gene clusters encoded in the sequenced bacteria, we 284 reported several novel putative lantibiotic clusters. Two of these clusters reported in our study 285 have already been characterized to encode two-component lantibiotics, bicereucin and 286 flavecins 10,12 . The lantibiotic cluster characterized in the current study attracted our attention 287 for its special attributes like a single RosM for processing of two RosA precursor peptides which are homologs of two-LanM processed two-component lantibiotics (Fig. 1) . These 289 peptides have altogether different core region, extended C-terminus and excessive Ser/Thr and 290 Cys residues. The putative two-component lantibiotic from an actinomycete was expected to 291 be having more lanthionine rings than already reported lantibiotics which are isolated from 292 firmicutes and hence would probably be more efficacious. Gly uncyclized ( Fig. 2A and 2C) . The structure of RosA2α, as suggested by sequence homology 37 o C. The RosA peptide digests were directly used for activity testing against the indicator strains.
455
Indicator strains were grown to 0.1 OD before spreading Nisin was prepared at 300 µM 456 concentration by dissolving 40 mg of 2.5% nisin powder (Sigma -N5764) in 0.05% acetic acid.
457

QUANTIFICATION AND STATISTICAL ANALYSIS
458
Protein quantitation was done with densitometry using lysozyme as a standard with ImageJ 1.48v 459 software. 
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KEY RESOURCES
